|
EP1361433A3
(en)
*
|
2002-04-09 |
2005-02-23 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo |
Method for estimating therapeutic efficacy of tumor necrosis factor (TNF)
|
|
US20040191782A1
(en)
*
|
2003-03-31 |
2004-09-30 |
Yixin Wang |
Colorectal cancer prognostics
|
|
US20050186577A1
(en)
|
2004-02-20 |
2005-08-25 |
Yixin Wang |
Breast cancer prognostics
|
|
WO2006013862A1
(ja)
*
|
2004-08-02 |
2006-02-09 |
Banyu Pharmaceutical Co., Ltd. |
Ｃｄｋ４阻害剤に対する薬剤感受性の予測方法
|
|
BRPI0518734A2
(pt)
*
|
2004-11-30 |
2008-12-02 |
Veridex Llc |
prognàstico de cÂncer de pulmço
|
|
KR100690250B1
(ko)
*
|
2005-01-31 |
2007-03-12 |
디지탈 지노믹스(주) |
폐암 진단용 마커
|
|
US7871774B2
(en)
|
2005-01-31 |
2011-01-18 |
Digital Genomics Inc. |
Markers for the diagnosis of lung cancer
|
|
US20070037186A1
(en)
|
2005-05-20 |
2007-02-15 |
Yuqiu Jiang |
Thyroid fine needle aspiration molecular assay
|
|
IL177006A0
(en)
|
2005-08-02 |
2006-12-10 |
Veridex Llc |
Predicting bone relapse of breast cancer
|
|
US20070130694A1
(en)
*
|
2005-12-12 |
2007-06-14 |
Michaels Emily W |
Textile surface modification composition
|
|
US20070207467A1
(en)
|
2006-03-01 |
2007-09-06 |
Ming Xu |
Detection of lymph node metastasis from gastric carcinoma
|
|
MX2008011356A
(es)
*
|
2006-03-03 |
2008-09-15 |
Veridex Llc |
Prueba molecular para predecir la recurrencia del cancer de colon de la etapa b de duke.
|
|
US8338109B2
(en)
|
2006-11-02 |
2012-12-25 |
Mayo Foundation For Medical Education And Research |
Predicting cancer outcome
|
|
US20080306881A1
(en)
*
|
2006-12-22 |
2008-12-11 |
X-Shares Advisors Llc |
Portfolio selection for custom indices of public securities based on state of domicile of issuing company
|
|
US20080206777A1
(en)
|
2007-02-27 |
2008-08-28 |
Nuclea Biomarkers, Llc |
Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors
|
|
CA2712773A1
(en)
*
|
2008-01-22 |
2009-07-30 |
Veridex, Llc |
Molecular staging of stage ii and iii colon cancer and prognosis
|
|
EP2271775A4
(en)
|
2008-04-08 |
2011-09-07 |
Nuclea Biomarkers Llc |
BIOMARKERGROUP FOR PREDICTING THE REPRESENTATION OF COLORECTAL CARCINOMA
|
|
EP2291553A4
(en)
|
2008-05-28 |
2011-12-14 |
Genomedx Biosciences Inc |
SYSTEMS AND METHODS FOR THE EXPRESSION-BASED DISTINCTION OF DIFFERENT CLINICAL ILLICIT STADIAS IN PROSTATE CANCER
|
|
US10407731B2
(en)
|
2008-05-30 |
2019-09-10 |
Mayo Foundation For Medical Education And Research |
Biomarker panels for predicting prostate cancer outcomes
|
|
JP2012508577A
(ja)
|
2008-11-12 |
2012-04-12 |
カリス ライフ サイエンシズ ルクセンブルク ホールディングス |
表現型を決定するためのエキソソームの使用方法およびそのシステム
|
|
US10236078B2
(en)
|
2008-11-17 |
2019-03-19 |
Veracyte, Inc. |
Methods for processing or analyzing a sample of thyroid tissue
|
|
US9495515B1
(en)
|
2009-12-09 |
2016-11-15 |
Veracyte, Inc. |
Algorithms for disease diagnostics
|
|
US9074258B2
(en)
|
2009-03-04 |
2015-07-07 |
Genomedx Biosciences Inc. |
Compositions and methods for classifying thyroid nodule disease
|
|
US9206482B2
(en)
|
2009-04-29 |
2015-12-08 |
Genomedx Biosciences Inc. |
Systems and methods for expression-based classification of thyroid tissue
|
|
CN102459636B
(zh)
|
2009-05-07 |
2016-08-17 |
威拉赛特公司 |
用于诊断甲状腺病症的方法和组合物
|
|
US10446272B2
(en)
|
2009-12-09 |
2019-10-15 |
Veracyte, Inc. |
Methods and compositions for classification of samples
|
|
KR20130056855A
(ko)
|
2010-03-01 |
2013-05-30 |
카리스 라이프 사이언스 룩셈부르크 홀딩스 |
치료진단용 생물학적 지표들
|
|
EP2556172A4
(en)
|
2010-04-06 |
2013-10-30 |
Caris Life Sciences Luxembourg Holdings |
CIRCULATING BIOMARKERS FOR DISEASES
|
|
US20130267443A1
(en)
|
2010-11-19 |
2013-10-10 |
The Regents Of The University Of Michigan |
ncRNA AND USES THEREOF
|
|
EP2791359B1
(en)
|
2011-12-13 |
2020-01-15 |
Decipher Biosciences, Inc. |
Cancer diagnostics using non-coding transcripts
|
|
ES2945036T3
(es)
|
2012-08-16 |
2023-06-28 |
Veracyte Sd Inc |
Pronóstico del cáncer de próstata mediante biomarcadores
|
|
US11976329B2
(en)
|
2013-03-15 |
2024-05-07 |
Veracyte, Inc. |
Methods and systems for detecting usual interstitial pneumonia
|
|
US12297505B2
(en)
|
2014-07-14 |
2025-05-13 |
Veracyte, Inc. |
Algorithms for disease diagnostics
|
|
WO2016073768A1
(en)
|
2014-11-05 |
2016-05-12 |
Veracyte, Inc. |
Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data
|
|
CN110506127B
(zh)
|
2016-08-24 |
2024-01-12 |
维拉科特Sd公司 |
基因组标签预测前列腺癌患者对术后放射疗法应答性的用途
|
|
US11208697B2
(en)
|
2017-01-20 |
2021-12-28 |
Decipher Biosciences, Inc. |
Molecular subtyping, prognosis, and treatment of bladder cancer
|
|
US11873532B2
(en)
|
2017-03-09 |
2024-01-16 |
Decipher Biosciences, Inc. |
Subtyping prostate cancer to predict response to hormone therapy
|
|
WO2018205035A1
(en)
|
2017-05-12 |
2018-11-15 |
Genomedx Biosciences, Inc |
Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness
|
|
US11217329B1
(en)
|
2017-06-23 |
2022-01-04 |
Veracyte, Inc. |
Methods and systems for determining biological sample integrity
|
|
EP4428157A3
(en)
|
2017-08-04 |
2024-12-11 |
Veracyte SD, Inc. |
Use of immune cell-specific gene expression for prognosis of prostate cancer and prediction of responsiveness to radiation therapy
|